Page last updated: 2024-11-05

zonisamide and Kussmaul Aphasia

zonisamide has been researched along with Kussmaul Aphasia in 1 studies

Zonisamide: A benzisoxazole and sulfonamide derivative that acts as a CALCIUM CHANNEL blocker. It is used primarily as an adjunctive antiepileptic agent for the treatment of PARTIAL SEIZURES, with or without secondary generalization.
zonisamide : A 1,2-benzoxazole compound having a sulfamoylmethyl substituent at the 3-position.

Research Excerpts

ExcerptRelevanceReference
"Zonisamide was administered at age 6 years, which was effective against her seizures, but selective mutism, violent behaviour, and lack of concentration developed at age 10 years."1.31Selective mutism and obsessive compulsive disorders associated with zonisamide. ( Hirai, K; Jozaki, K; Kimiya, S; Kumagai, N; Seki, T; Tabata, K, 2002)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hirai, K1
Kimiya, S1
Tabata, K1
Seki, T1
Jozaki, K1
Kumagai, N1

Other Studies

1 other study available for zonisamide and Kussmaul Aphasia

ArticleYear
Selective mutism and obsessive compulsive disorders associated with zonisamide.
    Seizure, 2002, Volume: 11, Issue:7

    Topics: Adolescent; Anticonvulsants; Epilepsies, Partial; Female; Humans; Isoxazoles; Male; Mutism; Obsessiv

2002